Mazumdar Claire insider trades
Mazumdar Claire has filed 14 Form 4s with the SEC that we hold, for Bicara Therapeutics Inc. (BCAX) (Chief Executive Officer, Director) and Relay Therapeutics, Inc. (RLAY) (Director). Across all of them we count 0 purchases worth $0 and 17 sales worth $4.1M reported on Form 4. In the last 12 months: 0 purchases ($0) and 17 sales ($4.1M). The largest single trade was a sale of 41,163 shares of Bicara Therapeutics Inc. worth $776.3K, dated 2025-11-24. The first filing on our record is dated 2025-06-11 and the latest 2026-08-12.
Bicara Therapeutics Inc. (BCAX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-10-13 | S, sale reported on Form 4 | 11,445 | $216.5K | 2025-10-15 |
| 2025-10-15 | S, sale reported on Form 4 | 13,289 | $250.4K | 2025-10-15 |
| 2025-10-16 | S, sale reported on Form 4 | 24,103 | $453.9K | 2025-10-20 |
| 2025-11-24 | S, sale reported on Form 4 | 41,163 | $776.3K | 2025-11-25 |
| 2026-03-04 | S, sale reported on Form 4 | 2,631 | $49.3K | 2026-03-06 |
| 2026-03-05 | S, sale reported on Form 4 | 1,786 | $33.5K | 2026-03-06 |
| 2026-03-06 | S, sale reported on Form 4 | 3,817 | $71.6K | 2026-03-06 |
| 2026-03-09 | S, sale reported on Form 4 | 36,766 | $704.8K | 2026-03-11 |
| 2026-03-18 | S, sale reported on Form 4 | 6,499 | $122.4K | 2026-03-20 |
| 2026-03-19 | S, sale reported on Form 4 | 6,905 | $129.7K | 2026-03-20 |
| 2026-03-20 | S, sale reported on Form 4 | 1,596 | $30.2K | 2026-03-20 |
| 2026-04-20 | S, sale reported on Form 4 | 15,000 | $354.1K | 2026-04-20 |
| 2026-05-18 | S, sale reported on Form 4 | 12,022 | $240.0K | 2026-05-20 |
| 2026-05-18 | S, sale reported on Form 4 | 2,978 | $60.6K | 2026-05-20 |
| 2026-07-10 | S, sale reported on Form 4 | 9,972 | $283.4K | 2026-07-14 |
| 2026-07-10 | S, sale reported on Form 4 | 28 | $831 | 2026-07-14 |
| 2026-08-10 | S, sale reported on Form 4 | 10,000 | $279.8K | 2026-08-12 |
Relay Therapeutics, Inc. (RLAY)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 2034671) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms